908 Devices Inc (MASS)
5.84
+0.08
(+1.48%)
USD |
NASDAQ |
Apr 30, 10:32
908 Devices Cash from Operations (Quarterly): -1.93M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.93M |
September 30, 2023 | -4.60M |
June 30, 2023 | -7.882M |
March 31, 2023 | -10.65M |
December 31, 2022 | -5.116M |
September 30, 2022 | -4.938M |
June 30, 2022 | -10.41M |
March 31, 2022 | -0.466M |
Date | Value |
---|---|
December 31, 2021 | -9.22M |
September 30, 2021 | -2.924M |
June 30, 2021 | -7.305M |
March 31, 2021 | -9.633M |
December 31, 2020 | 2.332M |
September 30, 2020 | 8.197M |
June 30, 2020 | -3.23M |
March 31, 2020 | -3.168M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.65M
Minimum
Mar 2023
8.197M
Maximum
Sep 2020
-4.434M
Average
-4.769M
Median
Cash from Operations (Quarterly) Benchmarks
Perspective Therapeutics Inc | -9.008M |
Retractable Technologies Inc | 1.894M |
Xtant Medical Holdings Inc | -0.915M |
Asensus Surgical Inc | -13.37M |
Catheter Precision Inc | -1.889M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 4.636M |
Cash from Financing (Quarterly) | 0.095M |
Free Cash Flow | -27.10M |
Free Cash Flow Per Share (Quarterly) | -0.0698 |
Free Cash Flow to Equity (Quarterly) | -2.263M |
Free Cash Flow to Firm (Quarterly) | -2.263M |
Free Cash Flow Yield | -14.40% |